A receptor agonist is a molecule that binds to and activates a cellular receptor, producing a biological signal that mimics the receptor’s natural ligand. Agonists are central tools in pharmacology research because they let scientists study what happens when a specific receptor is activated.
Agonists vs. Antagonists
- Agonist: binds AND activates the receptor (turns it on)
- Antagonist: binds but does NOT activate (blocks other ligands from binding)
- Inverse agonist: binds and produces the opposite of the receptor’s normal active state
- Partial agonist: binds and partially activates (less than the natural ligand)
Selectivity Matters
Most cell-surface receptors come in families with related members. A “GLP-1 receptor agonist” might activate GLP-1R selectively, or it might cross-react with the related GIP receptor. Researchers report selectivity ratios — for example, a compound described as “5× GIPR-selective” activates GIPR five times more potently than the related GLP-1R.
Multi-Receptor Agonists
Some research compounds are intentionally designed to activate multiple receptors simultaneously. For example:
- Single-receptor: Semaglutide (GLP-1R)
- Dual-receptor: Tirzepatide (GLP-1R + GIPR)
- Triple-receptor: Retatrutide (GLP-1R + GIPR + glucagon receptor)
Detailed comparison: GLP-1, GIP, and GLP-3 Receptor Agonists.
Research use only. Not for human consumption. Statements not evaluated by the US FDA.